Tagcyx Biotechnologies
Records under this name other than the patents Tagcyx Biotechnologies holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 8 of 8 · Back to Tagcyx Biotechnologies
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,837,964 | DNA Aptamer Binding to Cancer Cell Formerly held In force · High confidence | In force | High confidence | |
| US 8,686,130 | Novel Artificial Fluorescent Bases Lapsed on the fee record Ended Apr 1, 2026 · High confidence | Lapsed on the fee record | Ended Apr 1, 2026 | High confidence |
| US 7,615,628 | Imidazopyridine Derivatives Term ended Term ended Jan 17, 2026 · High confidence | Term ended | Term ended Jan 17, 2026 | High confidence |
| US 8,212,014 | Novel Artificial Base Pairs and Uses Thereof Lapsed on the fee record Ended Jul 3, 2024 · High confidence | Lapsed on the fee record | Ended Jul 3, 2024 | High confidence |
| US 9,857,362 | Method for preparing nucleic acid aptamer Lapsed on the fee record Ended Jan 2, 2022 · USPTO record | Lapsed on the fee record | Ended Jan 2, 2022 | USPTO record |
| US 9,285,319 | Nucleic Acid Base Analogs with Quenching and Fluorescent Activities and Applications Thereof Lapsed on the fee record Ended Mar 15, 2020 · High confidence | Lapsed on the fee record | Ended Mar 15, 2020 | High confidence |
| US 7,101,992 | Novel Nucleic Acid Base Pair Lapsed on the fee record Ended Sep 5, 2018 · High confidence | Lapsed on the fee record | Ended Sep 5, 2018 | High confidence |
| US 7,667,031 | Nucleic acid base pair Lapsed on the fee record Ended Feb 23, 2018 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2018 | USPTO record |